CSF α-Synuclein Does Not Discriminate Dementia with Lewy Bodies from Alzheimer's Disease

Authors:

Abstract
In this study, we assessed whether cerebrospinal fluid (CSF) levels of the biomarker α-synuclein have a diagnostic value in differential diagnosis of dementia with Lewy bodies (DLB) and Alzheimer's disease (AD). We also analyzed associations between